Success Story: From Neurology Research to EB-1A Approval After an RFE
Client’s Testimonial:
"Thank you for your efforts and time. Your support was fantastic.”
On July 22nd, 2026, we received another EB-1A (Alien of Extraordinary Ability) approval for a Postdoctoral Research Associate in the Field of Neurology (Approval Notice).
General Field: Neurology
Position at the Time of Case Filing: Postdoctoral Research Associate
Approval Notice Date: July 22nd, 2026
Processing Time: 11 months, 7 days (Premium Processing Requested)
Case Summary:
Research on neurological disease becomes especially consequential when it helps physicians better anticipate how infections, treatment choices, and patient characteristics may affect disease progression. This was the focus of a postdoctoral research associate in neurology whose work had already attracted substantial international attention. North America Immigration Law Group (Chen Immigration Law Associates) helped present this record in support of an EB-1A (Alien of Extraordinary Ability) petition.
A Record of Influence Beyond Publication
Rather than relying on publication volume alone, we emphasized evidence showing how the client's research had become a resource for other scientists. The client investigated issues including the relationship between acute viral infections and chronic autoimmune outcomes, differences in disease progression based on demographic onset factors, and the potential for infectious pathogens to increase the risk of clinical relapse.
The client's scholarly record included:
- 61 peer-reviewed journal articles, 13 published abstracts, and 5 book chapters
- 1,197 citations
- At least 30 completed peer reviews
- Editorial and advisory responsibilities for multiple scholarly journals
Citation analysis provided additional context for this influence. According to the evidence submitted, the client ranked among the top 1% of highly cited authors publishing on cognitive science topics over the preceding ten years.
The Challenge of an RFE
A premium processing upgrade was submitted on October 9th. On October 29th, USCIS issued an RFE, requiring the case to withstand additional scrutiny before a final decision could be reached.
For an EB-1A case, satisfying individual evidentiary criteria is only part of the analysis. The record must also establish, when considered as a whole, sustained national or international acclaim and a level of expertise associated with the small percentage who have risen to the top of their field.
In addressing the case, we therefore focused on connecting the client's individual accomplishments into a broader pattern of scientific influence. The evidence demonstrated authorship of scholarly articles, participation in judging the work of other researchers, and original scientific contributions whose significance could be measured through independent use and recognition.
From Additional Scrutiny to Approval
After the RFE extended the adjudication process, the case ultimately reached a favorable conclusion on July 22nd, 2026, 11 months and 7 days after the original filing.
For North America Immigration Law Group, this EB-1A approval demonstrated the importance of a cohesive evidentiary record when a petition faces additional USCIS scrutiny. The client's extensive scholarly output was reinforced by exceptional citation performance, documented international reliance, peer-review and editorial responsibilities, and independent expert recognition. Together, these elements supported the client's extraordinary ability and sustained influence in neurology, ultimately leading to approval after the RFE.